This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Today
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…
This Boston Beer Analyst Turns Bullish; Here Are Top 5 Upgrades For Today.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…
Penn Entertainment’s Losses Could Be ‘Higher For Longer,’ Analyst Says
Penn Entertainment shares rose despite disappointing Q1 results and low market share. BofA Securities downgrades to Buy.
This Texas Instruments Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Today
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…
MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: ‘We Were Surprised By Reported Deaths’
Despite MacroGenics' clinical activity, unexpected adverse events raise concerns. Analysts adjust ratings and price targets.
Fertility Solutions-Focused Progyny Stock Sinks After Soft Guidance; Analyst Says ‘Can No Longer Underwrite Sustained Healthy Growth In Forecasts’
Progyny reported first-quarter sales of $278.1 million, slightly below expectations due to increased clients and covered lives. KeyBanc Capital Markets downgraded Progyny from Overweight to Sector Weight, citing concerns about revenue visibility and customer behavior.
Orthopedic Devices Maker Treace Medical Concepts’ Gloomy Forecast Cast Concerns Over Long-Term Viability
Treace Medical Concepts reports Q1 EPS loss of $(0.30), sales hit $51.11 million, up 21%. Surge in procedure kits sold due to expanded surgeon base and product mix shift. FY24 sales guidance adjusted to $201M-$211M. Analysts downgrade, citing competitive challenges.
ZoomInfo Technologies Stock Dives On Heels Of Q1 Earnings: ‘Investors Need To Carefully Monitor The Macro’
Investors "will need to carefully monitor the macro to understand if ZoomInfo can hit their FY guide in the 2H," one analyst said.
Why Sprout Social Shares Got Crushed Friday
Shares of Sprout Social fell Friday after reporting first-quarter financial results Thursday and sharing Q2 guidance.Cloud software company Sprout Social (NASDAQ:SPT) saw shared fell 40% Friday after reporting first-quarter financial results Thursday.
Expedia Faces Challenges: Analysts Concerned About Vrbo’s Slow Start and B2C Growth
Benchmark analyst reiterated Buy rating and $180 price target for Expedia. Lowered guidance for slower growth and increased marketing spend.